Cover Image
Market Research Report

Europe 3D Cell Culture Market Forecast 2019-2027

Published by Inkwood Research Product code 910167
Published Content info 115 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe 3D Cell Culture Market Forecast 2019-2027
Published: September 6, 2019 Content info: 115 Pages
Description

KEY FINDINGS

The Europe 3D cell culture market is expected to project a CAGR of 11.66% during the forecast period. The rising awareness due to the conferences, workshops, and training programs is driving the growth of the market in the region.

MARKET INSIGHTS

The Europe 3D cell culture market is evaluated on the basis of the markets across the regions such as Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The partnerships and alliances between the players in the market have been instrumental in contributing to the market share. Reinnervate Ltd. collaborated with pre-clinical Oncology CRO Oncotest GmbH and developed 3D cell culture technology, which was responsible for driving the growth of the market. Spain 3D cell culture market faces challenges with regards to low investments and funding, resulting in an estimated low growth during the forecast period. Italy is one of the leading countries in terms of regenerative medicine. The country has recorded rapid growth with regards to prototyping computer-controlled techniques. The countries in the Europe region are undergoing developments in healthcare along with conferences in 3D cell culture, thereby resulting in the enhancement of the scope of 3D cell culture markets across the countries of the region.

COMPETITIVE INSIGHTS

Some of the major companies in the market are Thermo Fisher Scientific Inc., Nano3D Biosciences, Inc., Promocell GmbH, Merck KGaA, Tecan Trading AG, VWR International LLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 26685

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. SCAFFOLD FREE IS THE FASTEST GROWING 3D CELL CULTURE TECHNOLOGY
    • 3.2.2. STEM CELL RESEARCH IS THE WIDELY USED APPLICATION
    • 3.2.3. BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS ARE THE MAJOR END USER
    • 3.2.4. REAGENTS AND CONSUMABLES ARE THE MAJOR USED COMPONENT

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. GROWING DEMAND FOR 3D CELL CULTURE PLATFORMS
    • 4.2.2. TECHNOLOGICAL ADVANCEMENT
    • 4.2.3. INCREASED FOCUS ON THE REGENERATIVE MEDICINE
    • 4.2.4. RISING EUROPE R&D INVESTMENTS IN CELL BASED RESEARCH
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. EXPENSES ASSOCIATED WITH THE IMPLEMENTATION OF 3D CELL CULTURE
    • 4.3.2. LACK OF SKILLED PROFESSIONALS
    • 4.3.3. LACK OF CONSISTENCY IN RESULTS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. USAGE OF THE 3D CULTURE IN DRUG SCREENING AND ORGAN TRANSPLANTATION
    • 4.4.2. RISE IN THE PREVALENCE RATE OF CANCER
  • 4.5. MARKET CHALLENGES
    • 4.5.1. CHALLENGES ASSOCIATED WITH DEVELOPING OPTIMIZED 3D CELL CULTURE
    • 4.5.2. LIMITED DATA AVAILABILITY DUE TO RESTRICTED RESEARCH ON CELL CULTURE

5. MARKET BY TECHNOLOGY

  • 5.1. SCAFFOLD BASED
    • 5.1.1. HYDROGELS
    • 5.1.2. POLYMERIC SCAFFOLDS
    • 5.1.3. MICROPATTERNED SURFACE MICROPLATES
  • 5.2. SCAFFOLD FREE
    • 5.2.1. HANGING DROP MICROPLATES
    • 5.2.2. SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
    • 5.2.3. MICROFLUIDIC 3D CELL CULTURE
    • 5.2.4. MAGNETIC LEVITATIONS & 3D BIOPRINTING
  • 5.3. 3D BIOREACTORS

6. MARKET BY APPLICATION

  • 6.1. CANCER
  • 6.2. TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY
  • 6.3. DRUG DEVELOPMENT
  • 6.4. STEM CELL RESEARCH
  • 6.5. OTHER APPLICATION

7. MARKET BY END-USER

  • 7.1. BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS
  • 7.2. RESEARCH LABORATORIES AND INSTITUTES
  • 7.3. HOSPITALS AND DIAGNOSTIC CENTERS
  • 7.4. OTHER END USER

8. MARKET BY COMPONENT

  • 8.1. MEDIA
  • 8.2. REAGENTS AND CONSUMABLES

9. KEY ANALYTICS

  • 9.1. PORTER'S FIVE FORCES MODEL
    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE
    • 9.1.3. BARGAINING POWER OF BUYERS
    • 9.1.4. BARGAINING POWER OF SUPPLIERS
    • 9.1.5. THREAT OF COMPETITIVE RIVALRY
  • 9.2. POLITICAL & LEGAL, ECONOMIC, AND TECHNOLOGICAL ANALYSIS
  • 9.3. REGULATORY FRAMEWORK
  • 9.4. OPPORTUNITY MATRIX

10. GEOGRAPHICAL ANALYSIS

  • 10.1. EUROPE
    • 10.1.1. GERMANY
    • 10.1.2. THE UNITED KINGDOM
    • 10.1.3. FRANCE
    • 10.1.4. SPAIN
    • 10.1.5. ITALY
    • 10.1.6. REST OF EUROPE

11. COMPANY PROFILES

  • 11.1. 3D BIOTEK LLC
  • 11.2. BECTON DICKINSON AND COMPANY
  • 11.3. CORNING INC.
  • 11.4. EMULATE
  • 11.5. GE HEALTHCARE
  • 11.6. INSPHERO
  • 11.7. LONZA GROUP AG
  • 11.8. MERCK KGAA
  • 11.9. NANO3D BIOSCIENCES, INC.
  • 11.10. PROMOCELL GMBH
  • 11.11. TECAN TRADING AG.
  • 11.12. THERMO FISHER SCIENTIFIC INC.
  • 11.13. VWR INTERNATIONAL, LLC

LIST OF TABLES

  • TABLE 1 EUROPE 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • TABLE 2 EUROPE 3D CELL CULTURE MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 3 EUROPE SCAFFOLD BASED MARKET, 2019-2027 ($ MILLION)
  • TABLE 4 EUROPE SCAFFOLD BASED MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 5 EUROPE HYDROGELS MARKET, 2019-2027 ($ MILLION)
  • TABLE 6 EUROPE POLYMERIC SCAFFOLDS MARKET, 2019-2027 ($ MILLION)
  • TABLE 7 EUROPE MICROPATTERNED SURFACE MICROPLATES MARKET, 2019-2027 ($ MILLION)
  • TABLE 8 EUROPE SCAFFOLD FREE MARKET, 2019-2027 ($ MILLION)
  • TABLE 9 EUROPE SCAFFOLD FREE MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 10 EUROPE HANGING DROP MICROPLATES MARKET, 2019-2027 ($ MILLION)
  • TABLE 11 EUROPE SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING MARKET, 2019-2027 ($ MILLION)
  • TABLE 12 EUROPE MICROFLUIDIC 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • TABLE 13 EUROPE MAGNETIC LEVITATIONS & 3D BIOPRINTING MARKET, 2019-2027 ($ MILLION)
  • TABLE 14 EUROPE 3D BIOREACTORS MARKET, 2019-2027 ($ MILLION)
  • TABLE 15 EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 16 EUROPE CANCER MARKET, 2019-2027 ($ MILLION)
  • TABLE 17 EUROPE TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY MARKET, 2019-2027 ($ MILLION)
  • TABLE 18 EUROPE DRUG DEVELOPMENT MARKET, 2019-2027 ($ MILLION)
  • TABLE 19 EUROPE STEM CELL RESEARCH MARKET, 2019-2027 ($ MILLION)
  • TABLE 20 EUROPE OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)
  • TABLE 21 EUROPE 3D CELL CULTURE MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 22 EUROPE BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS MARKET, 2019-2027 ($ MILLION)
  • TABLE 23 EUROPE RESEARCH LABORATORIES AND INSTITUTES MARKET, 2019-2027 ($ MILLION)
  • TABLE 24 EUROPE HOSPITALS AND DIAGNOSTIC CENTERS MARKET, 2019-2027 ($ MILLION)
  • TABLE 25 EUROPE OTHER END USER MARKET, 2019-2027 ($ MILLION)
  • TABLE 26 EUROPE 3D CELL CULTURE MARKET, BY COMPONENT, 2019-2027 ($ MILLION)
  • TABLE 27 USAGE OF MEDIA IN DIFFERENT STAGES OF ORGANOIDS FORMATION
  • TABLE 28 EUROPE MEDIA MARKET, 2019-2027 ($ MILLION)
  • TABLE 29 EUROPE REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)
  • TABLE 30 EUROPE 3D CELL CULTURE MARKET, BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 2 EUROPE 3D CELL CULTURE MARKET, SHARE BY TECHNOLOGY 2018 & 2027 (%)
  • FIGURE 3 EUROPE 3D CELL CULTURE MARKET, BY SCAFFOLD BASED, 2019-2027 ($ MILLION)
  • FIGURE 4 EUROPE 3D CELL CULTURE MARKET, BY HYDROGELS, 2019-2027 ($ MILLION)
  • FIGURE 5 EUROPE 3D CELL CULTURE MARKET, BY POLYMERIC SCAFFOLDS, 2019-2027 ($ MILLION)
  • FIGURE 6 EUROPE 3D CELL CULTURE MARKET, BY MICROPATTERNED SURFACE MICROPLATES, 2019-2027 ($ MILLION)
  • FIGURE 7 EUROPE 3D CELL CULTURE MARKET, BY SCAFFOLD FREE, 2019-2027 ($ MILLION)
  • FIGURE 8 EUROPE 3D CELL CULTURE MARKET, BY HANGING DROP, MICROPLATES 2019-2027 ($ MILLION)
  • FIGURE 9 EUROPE 3D CELL CULTURE MARKET, BY SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING, 2019-2027 ($ MILLION)
  • FIGURE 10 EUROPE 3D CELL CULTURE MARKET, BY MICROFLUIDIC 3D CELL CULTURE, 2019-2027 ($ MILLION)
  • FIGURE 11 EUROPE 3D CELL CULTURE MARKET, BY MAGNETIC LEVITATIONS & 3D BIOPRINTING, 2019-2027 ($ MILLION)
  • FIGURE 12 EUROPE 3D CELL CULTURE MARKET, BY 3D BIOREACTORS, 2019-2027 ($ MILLION)
  • FIGURE 13 EUROPE 3D CELL CULTURE MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)
  • FIGURE 14 EUROPE 3D CELL CULTURE MARKET, BY CANCER, 2019-2027 ($ MILLION)
  • FIGURE 15 EUROPE 3D CELL CULTURE MARKET, BY TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY, 2019-2027 ($ MILLION)
  • FIGURE 16 EUROPE 3D CELL CULTURE MARKET, BY DRUG DEVELOPMENT, 2019-2027 ($ MILLION)
  • FIGURE 17 EUROPE 3D CELL CULTURE MARKET, BY STEM CELL RESEARCH, 2019-2027 ($ MILLION)
  • FIGURE 18 EUROPE 3D CELL CULTURE MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)
  • FIGURE 19 EUROPE 3D CELL CULTURE MARKET SHARE, BY END-USER, 2018 & 2027 (%)
  • FIGURE 20 EUROPE 3D CELL CULTURE MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS, 2019-2027 ($ MILLION)
  • FIGURE 21 EUROPE 3D CELL CULTURE MARKET, BY RESEARCH LABORATORIES AND INSTITUTES, 2019-2027 ($ MILLION)
  • FIGURE 22 EUROPE 3D CELL CULTURE MARKET, BY HOSPITALS AND DIAGNOSTIC CENTERS, 2019-2027 ($ MILLION)
  • FIGURE 23 EUROPE 3D CELL CULTURE MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)
  • FIGURE 24 EUROPE 3D CELL CULTURE MARKET SHARE, BY COMPONENT, 2018 & 2027 (%)
  • FIGURE 25 EUROPE 3D CELL CULTURE MARKET, BY MEDIA, 2019-2027 ($ MILLION)
  • FIGURE 26 EUROPE 3D CELL CULTURE MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)
  • FIGURE 27 PORTER'S FIVE FORCE MODEL
  • FIGURE 28 GERMANY 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 29 THE UNITED KINGDOM 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 30 FRANCE 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 31 SPAIN 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 32 ITALY 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
  • FIGURE 33 REST OF EUROPE 3D CELL CULTURE MARKET, 2019-2027 ($ MILLION)
Back to Top